Israel Englander’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.2M | Sell |
160,600
-88,600
| -36% | -$30.3M | 0.02% | 807 |
|
|
2026
Q1 | $87.7M | Buy |
249,200
+38,000
| +18% | +$13.5M | 0.04% | 511 |
|
|
2025
Q4 | $69.1M | Sell |
211,200
-66,700
| -24% | -$21.2M | 0.03% | 602 |
|
|
2025
Q3 | $78.4M | Buy |
277,900
+38,300
| +16% | +$11.1M | 0.03% | 568 |
|
|
2025
Q2 | $66.9M | Sell |
239,600
-40,600
| -14% | -$11.5M | 0.03% | 637 |
|
|
2025
Q1 | $87.3M | Buy |
280,200
+61,500
| +28% | +$18.2M | 0.05% | 416 |
|
|
2024
Q4 | $57M | Sell |
218,700
-66,600
| -23% | -$19.8M | 0.03% | 708 |
|
|
2024
Q3 | $91.9M | Sell |
285,300
-63,400
| -18% | -$20.7M | 0.04% | 466 |
|
|
2024
Q2 | $109M | Buy |
348,700
+113,700
| +48% | +$33.4M | 0.05% | 393 |
|
|
2024
Q1 | $66.8M | Sell |
235,000
-166,300
| -41% | -$48.7M | 0.03% | 658 |
|
|
2023
Q4 | $116M | Sell |
401,300
-62,400
| -13% | -$17M | 0.05% | 360 |
|
|
2023
Q3 | $125M | Sell |
463,700
-200,100
| -30% | -$49.9M | 0.06% | 287 |
|
|
2023
Q2 | $147M | Buy |
663,800
+163,100
| +33% | +$37.8M | 0.07% | 202 |
|
|
2023
Q1 | $121M | Sell |
500,700
-78,000
| -13% | -$19.1M | 0.07% | 264 |
|
|
2022
Q4 | $152M | Sell |
578,700
-12,000
| -2% | -$3.22M | 0.08% | 227 |
|
|
2022
Q3 | $133M | Buy |
590,700
+206,000
| +54% | +$49.9M | 0.08% | 211 |
|
|
2022
Q2 | $93.6M | Buy |
384,700
+81,200
| +27% | +$19.9M | 0.06% | 333 |
|
|
2022
Q1 | $73.4M | Buy |
303,500
+239,400
| +373% | +$55M | 0.04% | 484 |
|
|
2021
Q4 | $14.4M | Sell |
64,100
-59,500
| -48% | -$12.6M | 0.01% | 1758 |
|
|
2021
Q3 | $26.3M | Buy |
123,600
+33,700
| +37% | +$7.76M | 0.02% | 1081 |
|
|
2021
Q2 | $21.9M | Sell |
89,900
-42,800
| -32% | -$10.5M | 0.01% | 1119 |
|
|
2021
Q1 | $33M | Sell |
132,700
-68,400
| -34% | -$16.3M | 0.02% | 731 |
|
|
2020
Q4 | $46.2M | Sell |
201,100
-68,100
| -25% | -$15.7M | 0.03% | 500 |
|
|
2020
Q3 | $68.4K | Buy |
269,200
+109,700
| +69% | +$27.2M | 0.08% | 212 |
|
|
2020
Q2 | $37.6M | Sell |
159,500
-58,400
| -27% | -$13.3M | 0.05% | 417 |
|
|
2020
Q1 | $44.2M | Buy |
217,900
+18,300
| +9% | +$4M | 0.1% | 181 |
|
|
2019
Q4 | $48.1M | Buy |
199,600
+71,100
| +55% | +$15.7M | 0.06% | 383 |
|
|
2019
Q3 | $24.9M | Sell |
128,500
-48,900
| -28% | -$9.39M | 0.04% | 641 |
|
|
2019
Q2 | $32.7M | Buy |
+177,400
| New | +$31.8M | 0.05% | 522 |
|
|
2018
Q4 | – | Sell |
-250,000
| Closed | -$51.8M | – | 3713 |
|
|
2018
Q3 | $51.8M | Buy |
250,000
+150,000
| +150% | +$29.6M | 0.06% | 397 |
|
|
2018
Q2 | $18.5M | Buy |
100,000
+90,000
| +900% | +$15.9M | 0.02% | 908 |
|
|
2018
Q1 | $1.71M | Buy |
+10,000
| New | +$1.84M | ﹤0.01% | 2411 |
|
|
2015
Q3 | – | Sell |
-100,000
| Closed | -$15.4M | – | 3429 |
|
|
2015
Q2 | $15.4M | Buy |
+100,000
| New | +$16M | 0.03% | 748 |
|
|
2014
Q4 | – | Sell |
-21,300
| Closed | -$2.99M | – | 3880 |
|
|
2014
Q3 | $2.99M | Buy |
21,300
+1,300
| +7% | +$170K | 0.01% | 1609 |
|
|
2014
Q2 | $2.37M | Sell |
20,000
-130,900
| -87% | -$15.2M | 0.01% | 1660 |
|
|
2014
Q1 | $18.6M | Buy |
150,900
+70,100
| +87% | +$8.5M | 0.05% | 479 |
|
|
2013
Q4 | $9.22M | Sell |
80,800
-37,000
| -31% | -$4.21M | 0.03% | 766 |
|
|
2013
Q3 | $13.2M | Buy |
+117,800
| New | +$12.8M | 0.04% | 553 |
|
Other funds holding AMGN
Israel Englander's AMGN Position: Q2 2026 in Review
Israel Englander reduced its Amgen (AMGN) stake by 66% in Q2 2026, selling an estimated $51.6M and leaving 79,344 shares worth $28.7M. The position accounts for 0.01% of the portfolio, ranked #1300.
Israel Englander first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $241M in Q4 2015. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Israel Englander held 79,344 shares of Amgen worth $28.7M as of Q2 2026.
- Israel Englander sold 150,685 Amgen shares in Q2 2026, an estimated $51.6M.
- Amgen made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1300 holding.
- Israel Englander first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Israel Englander's Amgen position peaked at $241M in Q4 2015.
- 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.